Business · 04/02/2003
FDA Announces Guidance on Prussian Blue for Internal Contamination Treatment
The FDA has concluded that prussian blue is safe and effective for treating internal contamination with radioactive or nonradioactive thallium or radioactive cesium, and is now providing a guidance for industry to assist manufacturers in submitting new drug applications for prussian blue products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →